Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) FCF Margin (2016 - 2026)

Avanos Medical's FCF Margin history spans 13 years, with the latest figure at 11.77% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 2458.0% to 11.77% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.15%, a 768.0% decrease, with the full-year FY2025 number at 6.15%, down 768.0% from a year prior.
  • FCF Margin hit 11.77% in Q4 2025 for Avanos Medical, up from 3.94% in the prior quarter.
  • Over the last five years, FCF Margin for AVNS hit a ceiling of 175.42% in Q4 2021 and a floor of 7.28% in Q1 2024.
  • Historically, FCF Margin has averaged 16.48% across 5 years, with a median of 11.54% in 2024.
  • Biggest five-year swings in FCF Margin: soared 16850bps in 2021 and later tumbled -15108bps in 2022.
  • Tracing AVNS's FCF Margin over 5 years: stood at 175.42% in 2021, then plummeted by -86bps to 24.34% in 2022, then tumbled by -50bps to 12.23% in 2023, then surged by 197bps to 36.36% in 2024, then plummeted by -68bps to 11.77% in 2025.
  • Business Quant data shows FCF Margin for AVNS at 11.77% in Q4 2025, 3.94% in Q3 2025, and 2.4% in Q2 2025.